These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Genetic determinants of response to statins. Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675 [TBL] [Abstract][Full Text] [Related]
24. [Hypertension and hyperlipidemia]. Hansen HS; Larsen ML Ugeskr Laeger; 2009 Jun; 171(24):2028-30. PubMed ID: 19523369 [TBL] [Abstract][Full Text] [Related]
25. [The JUPITER study emphasizes primary prevention]. Olsson AG Lakartidningen; 2009 Jun 3-9; 106(23):1577. PubMed ID: 19583019 [No Abstract] [Full Text] [Related]
26. The origin of the statins. 2004. Endo A Atheroscler Suppl; 2004 Oct; 5(3):125-30. PubMed ID: 15531285 [No Abstract] [Full Text] [Related]
27. [JUPITER study (2). For now no reason to give statins to more people]. Koopmans RP Ned Tijdschr Geneeskd; 2009 Feb; 153(6):218-9. PubMed ID: 19271439 [No Abstract] [Full Text] [Related]
29. [JUPITER study, more reason to give statins as preventive measure - commentary]. Narkiewicz K Kardiol Pol; 2009 Mar; 67(3):346-7. PubMed ID: 19469067 [No Abstract] [Full Text] [Related]
30. [Contribution of Japanese researchers to the progress of studies in endocrinology and metabolism in the field of internal medicine in the last 100 years: Development of statins]. Yamamoto A Nihon Naika Gakkai Zasshi; 2002 Apr; 91(4):1134-6. PubMed ID: 12056005 [No Abstract] [Full Text] [Related]
31. [JUPITER no support of changed guidelines for cardiovascular prevention. Moderate absolute risk reduction and uncertain long term effects]. Håkansson J Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1460-1. PubMed ID: 19579433 [No Abstract] [Full Text] [Related]
32. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk. Stewart RA Future Cardiol; 2009 May; 5(3):231-6. PubMed ID: 19656039 [TBL] [Abstract][Full Text] [Related]
33. Quantitative and qualitative effects of rosuvastatin on LDL-cholesterol: what is the clinical significance? Rizzo M; Berneis K; Spinas GA; Rini GB; Kapur NK Int J Clin Pract; 2009 Mar; 63(3):478-85. PubMed ID: 19222633 [TBL] [Abstract][Full Text] [Related]
37. [The JUPITER study poses more questions than answers]. Håkansson J Lakartidningen; 2009 Jun 24-Jul 7; 106(26-27):1757. PubMed ID: 19731743 [No Abstract] [Full Text] [Related]
38. [Life style changes and drugs complete each other]. Olsson AG Lakartidningen; 2009 Aug 19-25; 106(34):2069. PubMed ID: 19769151 [No Abstract] [Full Text] [Related]
39. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor]. Olsson AG Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435 [No Abstract] [Full Text] [Related]
40. [Statin prescribing in the City of Zagreb (2001-2006) and their role in secondary prevention of cardiovascular events]. Stimac D; Culig J; John V Acta Med Croatica; 2009 May; 63(2):173-7. PubMed ID: 19580226 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]